Jing-Jing Zhao

1.8k total citations
37 papers, 1.5k citations indexed

About

Jing-Jing Zhao is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jing-Jing Zhao has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 24 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Jing-Jing Zhao's work include Immune Cell Function and Interaction (17 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Immunotherapy and Immune Responses (14 papers). Jing-Jing Zhao is often cited by papers focused on Immune Cell Function and Interaction (17 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Immunotherapy and Immune Responses (14 papers). Jing-Jing Zhao collaborates with scholars based in China, United States and Hong Kong. Jing-Jing Zhao's co-authors include Jian‐Chuan Xia, De-Sheng Weng, Qiu-Zhong Pan, Qi-Jing Wang, Shan-Shan Jiang, Ke Pan, Xiaofei Zhang, Xiao Hai Li, Jia He and Chang-Long Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Jing-Jing Zhao

37 papers receiving 1.5k citations

Peers

Countries citing papers authored by Jing-Jing Zhao

Since Specialization

Citations

This map shows the geographic impact of Jing-Jing Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing-Jing Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing-Jing Zhao more than expected).

Fields of papers citing papers by Jing-Jing Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing-Jing Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing-Jing Zhao. The network helps show where Jing-Jing Zhao may publish in the future.

Co-authorship network of co-authors of Jing-Jing Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Jing-Jing Zhao. A scholar is included among the top collaborators of Jing-Jing Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing-Jing Zhao. Jing-Jing Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Concept, Influencing Factors, and Interventions of Nursing Health Leadership: A Scoping Review 2025 ·Journal of Nursing Management ·Jing-Jing Zhao, (unknown), (unknown), (unknown), (unknown), Xiujie Zhang, Tieying Shi	2
2	CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma 2020 ·Cancer Immunology Immunotherapy ·Qiu-Zhong Pan, Qing Liu, (unknown), Jing-Jing Zhao, Qi-Jing Wang, Yong-Qiang Li, Yan Tang, (unknown), Jia He, Shi-Ping Chen, De-Sheng Weng, Jian‐Chuan Xia	15
3	PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer 2019 ·Journal for ImmunoTherapy of Cancer ·Zi-Qi Zhou, Jing-Jing Zhao, Qiu-Zhong Pan, Chang-Long Chen, Yuan Liu, Yan Tang, Qian Zhu, De-Sheng Weng, Jian‐Chuan Xia	27
4	<p>IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma</p> 2019 ·Cancer Management and Research ·(unknown), Jing-Jing Zhao, Zi-Qi Zhou, Qiu-Zhong Pan, Qian Zhu, Yan Tang, Jian‐Chuan Xia, De-Sheng Weng	24
5	Immunization-based scores as independent prognostic predictors in soft tissue sarcoma patients 2017 ·Journal of Cancer ·(unknown), Long Jiang, De-Sheng Weng, Yuanfang Li, Qiu-Zhong Pan, Jing-Jing Zhao, Yan Tang, Zhi-Wei Zhou, Jian‐Chuan Xia	3
6	PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma 2016 ·OncoImmunology ·Chang-Long Chen, Qiu-Zhong Pan, Jing-Jing Zhao, Ying Wang, Yong-Qiang Li, Qi-Jing Wang, Ke Pan, De-Sheng Weng, Shan-Shan Jiang, Yan Tang, Xiaofei Zhang, Hong-Xia Zhang, Zi-Qi Zhou, Yi-Xin Zeng, Jian‐Chuan Xia	51
7	High expression level of T-box transcription factor 5 predicts unfavorable survival in stage I and II gastric adenocarcinoma 2015 ·Oncology Letters ·Zheng Yan, (unknown), Wei Wang, (unknown), (unknown), Jing-Jing Zhao, (unknown), Shanshan Jiang, (unknown), Shuqiang Yuan, Haibo Qiu, Chunyu Huang, (unknown), Zhiwei Zhou, (unknown)	9
8	A Nomogram for Predicting the Benefit of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Hepatocellular Carcinoma 2015 ·Scientific Reports ·Qiu-Zhong Pan, Qi-Jing Wang, (unknown), Ke Pan, Yong-Qiang Li, Yaojun Zhang, Jing-Jing Zhao, De-Sheng Weng, Yan Tang, Li-Xi Huang, Jia He, Shi-Ping Chen, Miao-La Ke, Min-Shan Chen, Max S. Wicha, Alfred E. Chang, Yi-Xin Zeng, Qiao Li, Jian‐Chuan Xia	23
9	Clinical Activity of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Post-Mastectomy Triple-Negative Breast Cancer 2014 ·Clinical Cancer Research ·Ke Pan, (unknown), Yong-Qiang Li, Jing-Jing Zhao, Xiao Hai Li, Hui-Juan Qiu, De-Sheng Weng, Qi-Jing Wang, Qing Liu, Li-Xi Huang, Jia He, Shi-Ping Chen, Miao-La Ke, Yi-Xin Zeng, Jian‐Chuan Xia	77
10	Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells 2014 ·Scientific Reports ·Jing-Jing Zhao, Qiu-Zhong Pan, Ke Pan, De-Sheng Weng, Qi-Jing Wang, Xiao Hai Li, Lin Lv, Dandan Wang, Haixia Zheng, Shan-Shan Jiang, Xiaofei Zhang, Jian‐Chuan Xia	93
11	IL-17A Promotes Immune Cell Recruitment in Human Esophageal Cancers and the Infiltrating Dendritic Cells Represent a Positive Prognostic Marker for Patient Survival 2013 ·Journal of Immunotherapy ·Lin Lü, Ke Pan, Haixia Zheng, Jian‐Jun Li, Hui-Juan Qiu, Jing-Jing Zhao, De-Sheng Weng, Qiu-Zhong Pan, Dandan Wang, Shan-Shan Jiang, Alfred E. Chang, Qiao Li, Jian‐Chuan Xia	77
12	Decreased expression of the mitochondrial metabolic enzyme aconitase (ACO2) is associated with poor prognosis in gastric cancer 2013 ·Medical Oncology ·Peng Wang, Cong Mai, (unknown), Jing-Jing Zhao, (unknown), Zhao-Lei Zeng, Jing Yang, Wen-Hua Lu, Rui‐Hua Xu, Peng Huang	42
13	Decreased Expression of AZGP1 Is Associated with Poor Prognosis in Primary Gastric Cancer 2013 ·PLoS ONE ·Chun-yu Huang, Jing-Jing Zhao, Lin Lv, Yi-bing Chen, Yuanfang Li, Shan-Shan Jiang, Wei Wang, Ke Pan, Zheng Yan, (unknown), Dandan Wang, (unknown), Lei Yang, Zhi-Wei Zhou, Jian‐Chuan Xia	28
14	Decreased Expression of the FOXO3a Gene Is Associated with Poor Prognosis in Primary Gastric Adenocarcinoma Patients 2013 ·PLoS ONE ·(unknown), Jing-Jing Zhao, Chun-yu Huang, Qi-Jing Wang, Ke Pan, Dandan Wang, Qiu-Zhong Pan, Shan-Shan Jiang, Lin Lv, Xiang Gao, (unknown), (unknown), Min Zhi, Jian-chuan Xia	44
15	Intratumoral Expression of IL-17 and Its Prognostic Role in Gastric Adenocarcinoma Patients 2011 ·International Journal of Biological Sciences ·(unknown), Jian‐Chuan Xia, (unknown), Ke Pan, Wei Wang, Lin Lv, Jing-Jing Zhao, Qi-Jing Wang, Yong-Qiang Li, Shi-Ping Chen, Jia He, Li-Xi Huang, Miao-La Ke, Yi-bing Chen, (unknown), (unknown), Zhi-Wei Zhou, Alfred E. Chang, Qiao Li	90
16	Identification of LZAP as a New Candidate Tumor Suppressor in Hepatocellular Carcinoma 2011 ·PLoS ONE ·Jing-Jing Zhao, Ke Pan, Xiao Hai Li, Yi-bing Chen, (unknown), Lin Lv, Dandan Wang, Qiu-Zhong Pan, Min-Shan Chen, Jian-chuan Xia	31
17	Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells 2010 ·Cancer Biology & Therapy ·(unknown), Ke Pan, Min-Shan Chen, Qi-Jing Wang, Hui Wang, (unknown), Yong-Qiang Li, (unknown), Xiao Hai Li, Jing-Jing Zhao, Yi-bing Chen, (unknown), (unknown), (unknown), (unknown), Qizhou Lian, Jian‐Chuan Xia	34
18	Comparative Analysis of Cytotoxic T Lymphocyte Response Induced by Dendritic Cells Loaded with Hepatocellular Carcinoma -Derived RNA or Cell Lysate 2010 ·International Journal of Biological Sciences ·Ke Pan, Jing-Jing Zhao, Hui Wang, Xiao Hai Li, (unknown), (unknown), Yi-bing Chen, (unknown), Qing Liu, Jian‐Chuan Xia	23
19	Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK 2010 ·Chinese Journal of Cancer ·Qi-Jing Wang, Hui Wang, Ke Pan, Yong-Qiang Li, Li-Xi Huang, Shi-Ping Chen, Jia He, Miao-La Ke, Jing-Jing Zhao, Xiao Hai Li, (unknown), (unknown), (unknown), Yi-bing Chen, Jian‐Chuan Xia	31
20	Decreased expression of Neurensin-2 correlates with poor prognosis in hepatocellular carcinoma 2009 ·World Journal of Gastroenterology ·(unknown), (unknown), Jing-Jing Zhao, Hui Wang, (unknown), Yi-bing Chen, Ke Pan, Jian-chuan Xia	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact